drugset / Trial / NCT07510282

Probiotic Delivered to the Small Intestine Changes Microbiota

NCT07510282 ↗

Phase 1 Not yet recruiting 25 enrolled University College Dublin
RandomizedCrossoverSingle-blindTreatment

Summary

This study will determine whether encapsulation of probiotic bacteria using natural plant protein can enhance bacterial colonisation. Lactobacillus rhamnosus is an ideal strain for the intervention, as it has been shown to affect overall gut health, gut-brain axis, and brain function. Participants aged 25 to 65 years will be recruited and assessed on four occasions to compare the effects of the blood chemicals and bacterial composition in faeces of a 28-day ingestion of a yoghurt beverage with and without the probiotic strain of interest. The study window will be 70+/13 days. This study will provide important information regarding the physiological function of probiotics in the small intestine. Understanding the underlying physiological effects of targeted probiotic delivery to the intestine and the impact on the microbiome is important for health outcomes.

Timeline

Start
2026-04-15
Primary completion
2026-08
Completion
2026-12

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject L.rhamnosus R0011 strain Other / unclassified 2e+09 cells Oral

Indications

No indication recorded.